Targeted and stimuli–responsive mesoporous silica nanoparticles for drug delivery and theranostic use
Author:
Affiliation:
1. Department of Pharmaceutics, School of PharmacyChina Pharmaceutical University Nanjing Jiangsu People's Republic of China
2. School of Life Science and TechnologyChina Pharmaceutical University Nanjing Jiangsu People's Republic of China
Publisher
Wiley
Subject
Metals and Alloys,Biomedical Engineering,Biomaterials,Ceramics and Composites
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/jbm.a.36770
Reference166 articles.
1. Hybrid Nanomaterials Based on Iron Oxide Nanoparticles and Mesoporous Silica Nanoparticles: Overcoming Challenges in Current Cancer Treatments
2. Snap-Top Nanocarriers
3. In Vivo Computed Tomography/Photoacoustic Imaging and NIR-Triggered Chemo–Photothermal Combined Therapy Based on a Gold Nanostar-, Mesoporous Silica-, and Thermosensitive Liposome-Composited Nanoprobe
4. pH Responsive Release of Doxorubicin to the Cancer Cells by Functionalized Multi-Walled Carbon Nanotubes
5. The Optics of Human Skin
Cited by 47 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Physicochemical and biological properties of dental materials and formulations with silica nanoparticles: A narrative review;Dental Materials;2024-08
2. Magnetically modified-mitoxantrone mesoporous organosilica drugs: an emergent multimodal nanochemotherapy for breast cancer;Journal of Nanobiotechnology;2024-05-14
3. Cutting-edge advancements in anticancer drug delivery and scope for theranostics using biocompatible multifunctional mesoporous silica nanoparticles;Journal of Drug Delivery Science and Technology;2024-04
4. Environmental stimulus-responsive mesoporous silica nanoparticles as anticancer drug delivery platforms;Colloids and Surfaces B: Biointerfaces;2024-02
5. Advancements in application of chitosan and cyclodextrins in biomedicine and pharmaceutics: recent progress and future trends;RSC Advances;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3